Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2022
Mar. 31, 2021
CURRENT ASSETS    
Cash $ 17,072,419 $ 9,861,575
Accounts receivable 127,965 149,082
Prepaid expenses and other current assets 956,623 341,081
TOTAL CURRENT ASSETS 18,157,007 10,351,738
Property and equipment, net 441,238 160,976
Right-of-use lease asset 696,698 40,363
Patents, net 2,200 56,954
Restricted cash 87,506 46,726
Deposits 33,305 12,159
TOTAL ASSETS 19,417,954 10,668,916
CURRENT LIABILITIES    
Accounts payable 499,962 337,678
Due to related parties 155,742 118,520
Deferred revenue 344,547 114,849
Lease liability, current portion 126,905 42,543
Other current liabilities 696,893 761,636
TOTAL CURRENT LIABILITIES 1,824,049 1,375,226
Lease liability, less current portion 602,505 0
TOTAL LIABILITIES 2,426,554 1,375,226
STOCKHOLDERS’ EQUITY    
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2022 and 2021; 15,419,163 and 12,150,597 issued and outstanding at March 31, 2022 and 2021, respectively 15,421 12,152
Additional paid-in capital 147,446,868 129,331,542
Accumulated deficit (130,329,181) (119,913,090)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS’ EQUITY BEFORE NONCONTROLLING INTERESTS 17,133,108 9,430,604
NONCONTROLLING INTERESTS (141,708) (136,914)
TOTAL STOCKHOLDERS’ EQUITY 16,991,400 9,293,690
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 19,417,954 $ 10,668,916